AGuIX nanoparticles based on gadolinium have been proven to improve the radiosensitivity of cancers, which may regulate the anti-ferroptosis system by inhibiting the Nrf2-GSH-GPX4 signaling pathway [113]. The gene discussed is GPX4; the disease is cancer.